Hints and tips:
Related Special Reports
How global warming and deforestation are helping diseases jump from animals to humans and spreading fungal infections, while also fuelling antibiotic-resistant ‘superbugs’. Plus the impact on malaria, Lyme disease and the insurance industry
...Local NHS officials are now preparing a 10-year strategy for capital investment....
...London-based healthcare investor GHO Capital has this year hired advisers from JPMorgan to oversee a sales process for FairJourney Biologics, a contract research organisation that works on behalf of pharma...
...“This approach releases the toxic chemicals in plastics and increases community health risks for cancer and other non-communicable diseases,” she said....
...There has been extensive debate about how much capital banks need....
...more susceptible to poor health.”...
...“When we talk about links between climate change and human health, the most obvious thing is extreme heat, and extreme weather events,” says Alan Dangour, head of climate and health at the Wellcome Trust...
...“The climate crisis has numerous impacts on ecosystems, human health, animal health and food production, which also affect AMR,” according to a report titled “Bracing for Superbugs” published last year by...
...University of Singapore’s Saw Swee Hock School of Public Health and has spent years studying malaria in Malaysia....
...Opening and running medical practices is capital intensive....
...of California Berkeley School of Public Health....
...UK capital spending on health has fallen to half the OECD average since 2010. New fiscal rules must allow more. There is also a strong case for protecting spending on preventive health....
...Bulls can point to signs of improving health....
...Novavax is this year rolling out its second product: a malaria vaccine approved by the World Health Organization, which will help to grow its revenues from $531.4mn last year to a projected $854.2mn this...
...There’s ARK Genomic Revolution ETF, iShares Global Healthcare ETF, the SPDR Biotech ETF or Vanguard’s Health Care Index fund....
...Another factor worth considering for ESG-minded investors in the health sector is the pricing of these drugs....
It may be fashionable to be a catastrophist but the consequences can be alarming
...The future of the health service will be a key political battleground ahead of the next general election....
...current “targets and ambitions” were sufficient, but in a letter to shareholders that was sent on Thursday, the investors rejected this and warned that meeting the Paris goals was “essential to preserve the health...
...The early data helped Compass raise $285mn in a private placement of its shares last August from mainstream biotech funds including $10bn fund RA Capital and Surveyor Capital, an equities business owned...
...Silicon Valley’s blue-chip venture capital firm....
...The bank said in February that it had raised more than $2bn in seed capital from 27 contributors....
...McKernan is a former head of Innovate UK and currently a venture partner at life sciences venture capital firm SV Health Investors....
...Evan Seigerman, an analyst at BMO Capital Markets, said in a note that “the majority of this miss was due to a lack of supply, with Lilly likely shifting capacity to Zepbound during . . . Q1”....
...Each of these measures would provoke fierce resistance from backbenchers, the media and industry, and eat up vital political capital....
International Edition